Posted by Blue Matter on September 16th, 2021.
On September 9, 2021 at the MedInvest Neurological Diseases & Mental Health Disorders Conference, our own Varun Renjen moderated a panel discussion entitled, The Renaissance of Psychedelics in CNS Medicine. This video includes the full panel discussion and the Q&A session following it.
Thanks very much to all of our panelists for their expertise and participation!
- Henri Sant Cassia, Co-Founder and Managing Partner, The Conscious Fund
- Suran Goonatilake, Co-Founder, April 19 Discovery, Inc.
- Olivia Mannix, Founder, Chief Strategy Officer, Aphrodite Health
- James (Jim) Kuo, Chief Executive Officer, Return Health